ArticleFrontiers in oncology2024

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.

Francesco Angotzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.